| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 5e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |